Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2175 of 2228 entries
View as:

Phase II Study of BI 2536 in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00706498 Org: User:
Start: 09/30/06 End: - Due: -

Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02266524 Org: User:
Start: 01/31/05 End: - Due: -

Anticoagulants Comparative Benefit-risk Ratio in Real Life

Phase: N/A Priority: Normal
NCT ID: NCT02785354 Org: User:
Start: 03/01/16 End: 04/05/16 Due: 04/05/17

Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00710710 Org: User:
Start: 08/01/06 End: 10/14/08 Due: 10/14/09

Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02260050 Org: User:
Start: 06/30/04 End: - Due: -

RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00168805 Org: User:
Start: 11/30/04 End: - Due: -

Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT00730925 Org: User:
Start: 06/30/08 End: - Due: -

Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT02245490 Org: User:
Start: 01/31/03 End: - Due: -

Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of Season

Phase: N/A Priority: Normal
NCT ID: NCT01007721 Org: User:
Start: 10/31/09 End: - Due: -

LUX-Head & Neck 4: Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02131155 Org: User:
Start: 07/17/14 End: 08/22/16 Due: 08/22/17

Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01594125 Org: User:
Start: 05/31/12 End: 01/31/15 Due: 01/31/16

This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated.

Phase: N/A Priority: Normal
NCT ID: NCT03542344 Org: User:
Start: 06/04/18 End: 08/24/18 Due: 08/24/19

A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1

Phase: N/A Priority: Normal
NCT ID: NCT04059094 Org: User:
Start: 09/16/19 End: 04/24/20 Due: 04/24/21

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02221375 Org: User:
Start: 06/30/08 End: - Due: -

Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259803 Org: User:
Start: 10/31/07 End: - Due: -

A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05380947 Org: User:
Start: 06/23/22 End: 09/13/22 Due: 09/13/23

This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357

Phase: N/A Priority: Normal
NCT ID: NCT03279978 Org: User:
Start: 01/09/18 End: 08/30/18 Due: 08/30/19

Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01826370 Org: User:
Start: 05/31/12 End: 10/31/13 Due: 10/31/14

Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02209805 Org: User:
Start: 01/31/01 End: - Due: -

Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02194179 Org: User:
Start: 12/31/06 End: - Due: -

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.

Phase: N/A Priority: Normal
NCT ID: NCT02417844 Org: User:
Start: 04/30/15 End: 05/31/15 Due: 05/31/16

Influence of Fluvoxamine on the Pharmacokinetics of BI 409306

Phase: N/A Priority: Normal
NCT ID: NCT02853136 Org: User:
Start: 08/25/16 End: 10/25/16 Due: 10/25/17

Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Spray Dried BIBN 4096 BS After Inhalation Administration in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02199860 Org: User:
Start: 05/31/03 End: - Due: -

Influence of Bosentan on the Pharmacokinetics of Nintedanib

Phase: N/A Priority: Normal
NCT ID: NCT02667704 Org: User:
Start: 02/29/16 End: 03/31/16 Due: 03/31/17

This Study Tests in Healthy Korean Women Which Effects BI 409306 and a Birth-control Pill Have on Each Other

Phase: N/A Priority: Normal
NCT ID: NCT03193307 Org: User:
Start: 06/29/17 End: 12/01/17 Due: 12/01/18